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Escherichia coli Pathotypes Occupy Distinct Niches in the Mouse
Intestine
Jessica P. Meador,a Matthew E. Caldwell,a Paul S. Cohen,b Tyrrell Conwaya
Department of Microbiology and Plant Biology, University of Oklahoma, Norman, Oklahoma, USAa; Department of Cell and Molecular Biology, University of Rhode Island,
Kingston, Rhode Island, USAb
Since the first step of the infection process is colonization of the host, it is important to understand how Escherichia coli patho-
gens successfully colonize the intestine. We previously showed that enterohemorrhagic O157:H7 strain E. coli EDL933 colonizes
a niche in the streptomycin-treated mouse intestine that is distinct from that of human commensal strains, which explains how
E. coli EDL933 overcomes colonization resistance imparted by some, but not all, commensal E. coli strains. Here we sought to
determine if other E. coli pathogens use a similar strategy. We found that uropathogenic E. coli CFT073 and enteropathogenic E.
coli E2348/69 occupy intestinal niches that are distinct from that of E. coli EDL933. In contrast, two enterohemorrhagic strains,
E. coli EDL933 and E. coli Sakai, occupy the same niche, suggesting that strategies to prevent colonization by a given pathotype
should be effective against other strains of the same pathotype. However, we found that a combination of commensal E. coli
strains that can prevent colonization by E. coli EDL933 did not prevent colonization by E. coli CFT073 or E. coli E2348/69. Our
results indicate that development of probiotics to target multiple E. coli pathotypes will be problematic, as the factors that gov-
ern niche occupation and hence stable colonization vary significantly among strains.
Pathogenic strains of Escherichia coli, without exception, mustfirst colonize the host gastrointestinal tract before causing dis-
ease (1). Freter (2) postulated that successful competition for nu-
trients allows intestinal bacteria to colonize, whichwedefine as the
ability to achieve and maintain a stable population without rein-
troduction. Freter’s nutrient niche hypothesis theoretically ex-
plains the succession of community members of the intestinal
microbiota, as well as the ability of enteric pathogens to overcome
colonization resistance and thereby invade the microbiota (3).
How invading pathogens compete for nutrients with the estab-
lished microbial residents is an open question.
Recently, we developed a colonization resistance model in
streptomycin-treated mice, in which a given strain cannot colo-
nize mice that are precolonized with the same E. coli strain (4, 5).
We demonstrated that several human-derived E. coli strains are
able to overcome colonization resistance imparted by other E. coli
strains and thereby cocolonize the intestine. The results establish
that various commensals, as well as enterohemorrhagic E. coli
(EHEC) strain O157:H7, occupy distinct niches in the intestine
and therefore can properly be described as ecotypes and patho-
types, respectively.
A series of previous studies from our laboratories indicate that
in themouse intestine different pathogenic and commensal E. coli
strains each use a different set of approximately 6 sugars of the
more than 18 sugars that E. coli potentially is capable of using in
vitro (6–11). This led us to hypothesize that invading E. coli patho-
gens overcome colonization resistance by taking advantage of nu-
trients that are available because they are not used by resident
commensal E. coli strains (8).While this is an attractivemodel and
seemingly is correct, we subsequently found that the intestine se-
lects forflhDmutants ofE. coliK-12,which are superior colonizers
not by virtue of using different sugars but rather by using the same
sugars better than its wild-type parent (12, 13). Intriguingly, the
mouse intestine also selects for envZmissensemutants that hyper-
phosphorylate OmpR, causing them to have an altered outer
membrane protein profile, to grow more slowly in vitro on cecal
mucus as well as severalmono- and disaccharides, and to outcom-
pete their wild-type parent during colonization of the streptomy-
cin-treated mouse intestine (14). Furthermore, we found that the
envZ mutants occupy an intestinal niche in which galactose is
available but fromwhich the wild-type parent is excluded (14). To
explain these results, we invoked the “restaurant” hypothesis (14),
which states that sugars aremade available locally to commensalE.
coli by polysaccharide-degrading anaerobes within themixed bio-
films that E. coli inhabits (15). Collectively, these competitive
strategies potentially allow different ecotypes and pathotypes to
occupy different niches.
Competition between invading pathogens and the microbiota
undergirds the concept of probiotics as a preventative measure.
That there is stiff competition between strains for nutrients in the
intestine emphasizes the potential of probiotics to limit the avail-
ability of nutrients required by pathogens to colonize (9). Indeed,
we recently showed that while no single commensal E. coli strain
can exert colonization resistance against E. coli EDL933 (the pro-
totypical O157:H7 strain), a mixture of several commensals could
(4). By considering the profiles of sugars utilized by several com-
mensalE. coli, we found two strains that overlapmost but not all of
the sugar catabolism capacity of E. coli EDL933 and together are
able to prevent the pathogen fromcolonizing (5).One of these two
strains, E. coli Nissle 1917, has long been recognized as having
probiotic potential against dysentery and traveler’s diarrhea (16),
and the other, E. coli HS, is well established as an excellent colo-
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nizer of primates (17). It is interesting to consider the possibility
that appropriate mixtures of commensal E. coli strains might con-
sume the nutrients needed by enteric pathogens, in general, to
colonize and thereby prevent disease. While preventing coloniza-
tion by E. coli EDL933 is a promising step in the development of
probiotics, this approach has not been tested for other E. coli
pathotypes, nor is it known whether different pathotypes occupy
distinct niches in the intestine.
Herewe testedwhether uropathogenic E. coliCFT073 (UPEC),
enteropathogenic E. coli E2348/69 (EPEC), and the enterohemor-
rhagic E. coli EDL933 (EHEC) occupy the same or different niches
in the streptomycin-treatedmouse intestine. Furthermore, we de-
termined whether the combination of commensal strains previ-
ously shown to exert colonization resistance to E. coli EDL933 (5)
could also prevent colonization by the pathogens E. coli CFT073
and E. coli E2348/69. The results demonstrate that different E. coli
pathotypes indeed occupy distinct intestinal niches and commen-
sals that prevent colonization by one pathotype do not prevent
colonization by others.We discuss the implication of these results
for designing strategies to prevent colonization by enteric patho-
gens.
MATERIALS AND METHODS
Bacterial strains. The strains used in this study are listed in Table 1. All
strains were made Strr (streptomycin resistant) to allow them to colonize
streptomycin-treated mice. In addition, the Strr strains were also made
eitherNalr (nalidixic acid resistant) orRifr (rifampin resistant) to facilitate
plate counting of specific populations in streptomycin-treatedmouse col-
onization experiments, as described previously (5, 6, 10). Each of the
isogenic Strr, Strr Nalr, and Strr Rifr strains were competed against one
another in control experiments andwere found to cocolonizemice, which
confirms that the selectable markers did not impact their relative fitness
for colonization (references 5, 6, and 10 and data not shown). E. coli
EDL933 is the prototype strain of EHEC strain O157:H7 (18). E. coli Sakai
was isolated from contaminated vegetables during a massive outbreak in
Japan and is serotypically identical to E. coli EDL933 (19). E. coli CFT073
is the sequenced prototype UPEC strain and readily colonizes the gastro-
intestinal (GI) tract (20), and E. coli E2348/69 is the sequenced prototype
EPEC strain (21). E. coliNissle 1917 (16) and E. coliHS (17) are commen-
sal human isolates. To facilitate plate counting of E. coli HS when colo-
nized with more than one other strain, we used E. coliHS Strr uxaC::kanR
because it provides an alternative selectable marker (kanamycin resis-
tance), but loss of uronic isomerase and hence the ability to grow on
hexuronic acids does not affect its colonizing ability, as it cocolonizes with
its wild-type parent E. coli HS Strr Nalr (5).
Streptomycin-treated mouse model. The streptomycin-treated
mouse model is used extensively to study the colonization of Escherichia
coli in themouse large intestine (22). Briefly, three 6-week-old CD-1mice
were obtained from Charles River Laboratories and given streptomycin
sulfate (5 g/liter) in their drinking water for 24 h. Streptomycin sulfate
selectively eliminates the resident facultative anaerobes in the intestine
with little disruption of the anaerobe community, opening a niche for
introducedE. coli strains to colonize (23). Following treatmentwith strep-
tomycin sulfate, themice were starved of food andwater for 14 h and then
fed approximately 105 CFU of E. coli strain(s) in 1ml of 20% sucrose (day
0). Following consumption of the bacterial suspension, food and water (5
g/liter streptomycin sulfate) were given to the mice ad libitum for the
duration of the experiment. After 10 days, food and water again were
withheld for 14 h, and the mice were fed approximately 105 CFU of a
challenge strain. Fecal sampleswere taken after 5 h and 24h and then every
other day thereafter for 21 days. Antibiotic resistance was used to distin-
guish the strains in fecal plate counts. Feces were homogenized in 1%
tryptone, serially diluted, and plated on lactose-MacConkey agar supple-
mented with the appropriate antibiotics, as follows: streptomycin sulfate
(100 mg/ml), nalidixic acid (50 mg/ml), rifampin (50 mg/ml), and kana-
mycin (40 mg/ml). Each colonization experiment was repeated, and the
values for the sixmice (ormore)were averaged. The log10 CFU/g feceswas
determined for each strain at each time point ( the standard error), and
a Student t test was performed. A difference of101 CFU/g feces between
strains in all cases was statistically significant (P 0.05).
Enumeration ofE. coli strains frommouse intestinalmucus.BothE.
coli HS uxaC::kan Strr Kanr and E. coli Nissle 1917 Strr Rifr were fed to
sets of three streptomycin-treated mice and allowed to colonize for 10
days. On day 10, 105 CFU of E. coli E2348/69 Strr Nalr (EPEC) or E. coli
CFT073 Strr Nalr (UPEC) was fed to individual sets of three precolonized
mice and cocolonization was monitored. After 5 days, we confirmed that
all three organisms had cocolonized in the mice, and then the mice were
sacrificed, the intestinal tract was removed, sectioned, opened, and gently
washed, the mucosal layer of each section was collected, and the pop-
ulation of each strain of E. coliwas quantified as previously described (4,
24). Prior to removing the intestinal tract, the bladder of each mouse was
removed and placed in 5 ml HEPES-Hanks buffer (pH 7.4) and analyzed
for the presence of any of the experimentally introduced E. coli strains.
Briefly, the bladder and its contents were homogenized by vortexing,
followed by serial dilution in 1% tryptone broth and plating onto Mac-
Conkey agar containing the appropriate antibiotics for each strain.
RESULTS
Commensal E. coli cannot prevent colonization by UPEC and
EPEC. If it is true that invading pathogens must overcome colo-
nization resistance by competing with the microbiota for intesti-
nal niches, then commensal strains that occupy all preferred
niches would prevent colonization by pathogens. Previously, we
showed that mixtures of human commensal E. coli ecotypes (e.g.,
E. coli HS and E. coli Nissle 1917) could prevent EHEC strain
EDL933 from colonizing the streptomycin-treated mouse intes-
tine (4, 5). If it is true that other E. coli pathogens prefer the same
intestinal niches as EHEC, then E. coli HS and E. coli Nissle 1917
should exert colonization resistance against those pathogens. To
test this possibility, we precolonized streptomycin-treatedmice by
feeding them 105 CFU each of E. coli HS and E. coli Nissle 1917,
which both colonized at between 108 and 109 CFU per g of feces
(Fig. 1). On day 10 of the experiments, mice that were precolo-
TABLE 1 E. coli strains used in this study
E. coli strain
Relevant genotype or
description
Source or
reference
CFT073 Wild-type O6:H1 20
CFT073 Strr Spontaneous Strr Karen Krogfelt
CFT Strr Nalr Spontaneous Strr Nalr This study
EDL933 Wild-type O157:H7 Allison O’Brien
EDL933 Strr Spontaneous Strr 10
EDL 933 Strr Rifr Spontaneous Strr Rifr 10
E2348/69 Wild-type O127:H6 Jim Nataro
E2348/69 Strr Spontaneous Strr This study
E2348/69 Strr Nalr Spontaneous Strr Nalr This study
HS Wild type Dave Rasko
HS Strr Spontaneous Strr 5
HS Strr uxaC::kan Strr uxaC::kan 5
Nissle 1917 Wild type Dean Hamer
Nissle 1917 Strr Spontaneous Strr 6
Nissle 1917 Strr Rifr Spontaneous Strr Rifr 6
Sakai Wild-type O157:H7 Beth Whitman
Sakai Strr Spontaneous Strr This study
Sakai Strr Nalr Spontaneous Strr Nalr This study
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nized with E. coli HS and E. coli Nissle 1917 were challenged by
association (i.e., feeding) with a third strain, either 105 CFU of E.
coli CFT073, a UPEC strain, or 105 CFU of E. coli E2348/69, an
EPEC strain. Both UPEC (Fig. 1A) and EPEC (Fig. 1B) grew from
low to high numbers in competition with precolonized E. coli HS
and E. coliNissle 1917, reaching populations between 107 and 108
CFU per g of feces by day 13 of the experiments. These results
indicate that UPEC and EPEC occupy at least one intestinal niche
in mice that is not occupied by either E. coli HS or E. coli Nissle
1917. The results do not determine whether or not the additional
niches occupied by UPEC and EPEC are the same, but it is clear
that no single strategy for stimulating colonization resistance
against more than one E. coli pathotype will be effective.
Localization of E. coli HS, E. coli Nissle 1917, E. coli EPEC,
and E. coli UPEC in the streptomycin-treated mouse GI tract.
The ability of EPEC strain E2348/69 and UPEC strain CFT073 to
cocolonizemice that were precolonized by the human commensal
strains E. coli HS and E. coli Nissle 1917 (Fig. 1) suggests that the
pathogenic strains are competing for different niches.WhileE. coli
HS and E. coliNissle 1917 have been previously shown to colonize
the streptomycin-treated mouse large intestine, primarily the ce-
cum (20), the two pathogenic strains of E. coli, EPEC and UPEC,
have not been correlated to any specific region of the streptomy-
cin-treated mouse GI tract. It may be that the pathogenic strains
prefer to occupy the small intestinewhileE. coliHSandNissle1917
colonize the large intestine. To answer this question, the entire
mouse GI tract was excised and cut into sections corresponding to
the jejunum, ileum, cecum, and colon, each section was cut open
and gently washed, and themucus layer was collected by scraping;
then, the population of each E. coli strain was enumerated by plate
counting of the mucus samples (Table 2). When E. coliHS, E. coli
Nissle 1917, and EPECwere competed against each other, roughly
the same number of each bacterium was recovered from each
section of the GI tract (Table 2). The same results were observed
when E. coli HS, E. coli Nissle 1917, and UPEC were competed
against each other, withE. coliHS showing a 2-fold increasewithin
the jejunum. The numbers of E. coli recovered from each section
of the intestinal system were highest within the cecal and colonic
mucosal layers. No inflammation was noted in any of the animals
colonized with UPEC or EPEC. In addition, none of the strains
could be recovered from the bladder (data not shown). These
results are in agreement with studies of other pathogens that in-
dicate that the streptomycin-treated mouse is a colonization
model, not a pathogenesis model (4, 8). It was noted previously
that E. coli EDL933 colonizes the streptomycin-treated mouse ce-
cum in the highest numbers, and histology showed that all tissues
were normal (25). Our results show that EPEC strain E2348/69
colonizes the colon in the highest numbers and UPEC strain
CFT073 colonizes the GI tract in the highest numbers in the ce-
cum but does not infect the urinary tract.
Two EHEC strains occupy the same intestinal niche. Differ-
ent E. coli pathotypes share a “backbone” genome but have dis-
tinctly different gene complements (26–28). These genetic differ-
ences could allow various pathogens to occupy distinct niches in
the intestine by bestowing different physiological traits that pro-
mote different strain-strain interactions in the intestine. Alterna-
tively, genetically similar strains might be expected to occupy the
same niche in the intestine because they express the same physio-
logical traits. Previously, we showed that several E. coli ecotypes
exert colonization resistance against isogenic strains (4). So, we
sought to determine if the highly similar EHEC strains E. coli
EDL933 and E. coli Sakai occupy the same or different niches (Fig.
2). These EHEC strains share 99.9% sequence identity in their
FIG 1 UPEC and EPEC colonization of mice precolonized with a combination of commensal E. coli strains HS and Nissle 1917. (A) Two sets of 3 mice were
fed 105 CFU of E. coliHS Strr uxaC::kan and E. coliNissle 1917 Strr Rifr and 10 days later were fed 105 CFU of E. coli CFT073 Strr Nalr (UPEC). (B) Two sets of
3 mice were fed 105 CFU of E. coli HS Strr uxaC::kan and E. coli Nissle 1917 Strr Rifr and 10 days later were fed 105 CFU of E. coli E2348/69 Strr Nalr (EPEC).
TABLE 2 Population distribution of E. coli strains HS, Nissle, and
E2348/69 (EPEC) or CFT073 (UPEC) within the small intestinal
(jejunum), ileal, cecal, and colonic mucus layers
Expt and location
Mean log10 CFU SEM
a for E. coli strain:
HS Nissle E2348/69 CFT073
E2348/69 cocolonization
Jejunumb 4.7 0.1 4.2 0.7 4.2 0.9
Ileum 4.2 0.1 3.8 0.1 3.8 0.2
Cecum 6.1 0.2 6.5 0.2 5.8 0.3
Colon 6.0 0.5 6.8 0.1 6.4 0.6
Fecesc 6.9 0.9 7.3 0.7 6.3 0.2
CFT073 cocolonization
Jejunumb 4.7 0.3 2.8 0.6 2.4 0.3
Ileum 3.9 0.4 3.9 0.7 3.5 1.1
Cecum 5.1 0.2 5.4 0.4 5.5 0.6
Colon 5.7 0.2 4.8 0.5 4.7 0.7
Fecesc 6.4 0.1 6.1 0.3 6.2 0.5
a Data from sets of 3 mice. SEM, standard error of the mean.
b Mucus taken from below the stomach to the proximal ileum.
c Fecal counts are in CFU/gram of feces collected on the day of intestinal sampling, as
described in the text.
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protein-coding genes (29), and the relatively minor genomic dif-
ferences between them can be attributed to how the two genomes
were annotated (28). Mice were precolonized with105 CFU of E.
coli EDL933 by feeding and on day 10 challenged by association
with 105 CFU E. coli Sakai (Fig. 2A). E. coli Sakai failed to grow to
higher numbers and over the next 10 days of the experiment was
almost eliminated from the intestine. In a reciprocal experiment,
micewere precolonizedwithE. coli Sakai and onday 10 challenged
by association with 105 CFU of E. coli EDL933 (Fig. 2B). Again, E.
coli EDL933 failed to grow to higher numbers and was almost
eliminated from the intestine. These results indicate that the
closely related EHEC strains exert colonization resistance against
one another and occupy the same intestinal niches.
UPEC and EPEC occupy intestinal niches that are distinct
from that of EHEC. Since UPEC and EPEC can grow from low to
high numbers in competition with precolonized E. coli HS and E.
coli Nissle 1917 (Fig. 1) but E. coli EDL933 cannot (5), it can be
inferred that UPEC and EPEC occupy intestinal niches that are
distinct from that of EHEC. To test this possibility, we determined
whether or not UPEC could overcome colonization resistance by
the EHEC strain E. coli EDL933 (Fig. 3). Mice were precolonized
with 105 CFU of EHEC by feeding and on day 10 challenged by
FIG 2 Competitive colonization between EHEC strains. (A) Two sets of 3 mice were fed 105 CFU of E. coli EDL933 Strr Rifr and 10 days later were fed 105 CFU
of E. coli Sakai Strr Nalr. (B) The reciprocal experiment was conducted.
FIG 3 Competitive colonizations between E. coli pathotypes and an enterohemorrhagic strain. (A and B) Two sets of 3 mice were fed 105 CFU of E. coli EDL933
Strr Rifr and 10 days later were fed 105 CFU of E. coli CFT073 Strr Nalr (UPEC) (A), and the reciprocal experiment was conducted (B). (C and D) Two sets of 3
mice were fed 105 CFU of E. coli EDL933 Strr Rifr and 10 days later were fed 105 CFU of E. coli E2348/69 Strr Nalr (EPEC) (C), and the reciprocal experiment was
conducted (D).
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association with 105 CFU of UPEC (Fig. 3A). UPEC overcame
colonization resistance and grew to approximately 107 CFU per g
of feces, suggesting that UPEC colonizes at least one niche that is
not occupied by EHEC, whereas the population of EHECdeclined
from between 105 and 106 to approximately 104 CFU per g of feces
for the duration of the 21-day experiment, suggesting that UPEC
outcompetes EHEC in at least one niche. In a reciprocal experi-
ment, mice were precolonized with UPEC and on day 10 chal-
lenged by association with 105 CFU of EHEC (Fig. 3B). UPEC
colonized at between 107 and 108 CFU per g feces, whereas EHEC
failed to grow further but persisted between 104 and 102 CFU per
g of feces in competition with precolonized UPEC. Since in the
absence of competition EHEC typically colonizes mice at approx-
imately 107 CFU per g feces (10), these results indicate that UPEC
outcompetes EHEC in its preferred niche(s).
In analogous experiments, we determined whether or not
EPEC and EHEC occupy distinct niches (Fig. 3). Mice were
precolonized with 105 CFU of EHEC by feeding and on day 10
challenged by association with 105 CFU of EPEC (Fig. 3C).
EPEC grew to approximately 107 CFU per g of feces, whereas
the population of EHEC declined from approximately 106 to
between 104 and 103 CFU per g of feces, suggesting that EPEC
outcompetes EHEC in at least one niche. In a reciprocal exper-
iment, mice were precolonized with EPEC and on day 10 chal-
lenged by association with 105 CFU of EHEC (Fig. 3D). EHEC
failed to grow further but persisted between 104 and 102 CFU
per g of feces in competition with precolonized EPEC, which
colonized at approximately 107 CFU per g feces. These results
corroborate the finding that EPEC outcompetes EHEC in its
preferred niche(s). We conclude that UPEC and EPEC occupy
intestinal niches that are not occupied by EHEC and apparently
outcompete EHEC in its preferred niches.
UPEC and EPEC intestinal niches. The data described above
clearly demonstrate thatUPECandEPECoccupy intestinal niches
that are distinct from those occupied by EHEC (Fig. 3) but do not
distinguish whether or not their niches are the same or different.
Therefore, we sought to determine if UPEC and EPEC occupy
distinct intestinal niches by competing them in challenge experi-
ments (Fig. 4). Mice were precolonized with 105 CFU of UPEC by
feeding and on day 10 challenged by association with 105 CFU
EPEC (Fig. 4A). EPEC failed to grow further but remained in the
intestine at between 102 and 103 CFU per g of feces, whereas the
population of UPEC remained at approximately 109 CFU per g of
feces, suggesting that EPEC cannot compete effectively in any of
the niches occupied by precolonized UPEC. In the reciprocal ex-
periment, mice were precolonized by feeding 105 CFU of EPEC
and on day 10 challenged by association with 105 CFU of UPEC
(Fig. 4B). UPEC grew to approximately 106 CFU per g of feces,
whereas the population of EPEC remained at approximately 109
CFU per g of feces, suggesting that UPEC occupies an additional
niche that is not occupied by EPEC. In summary,UPEC andEPEC
both occupy niches that are not occupied by EHEC (Fig. 3). UPEC
occupies at least one niche that is not occupied by EPEC (Fig. 4B).
However, EPEC does not appear to occupy any niches that are not
occupied by UPEC (Fig. 4A). Finally, the niches shared by UPEC
and EPEC are not occupied by commensal strains E. coliHS and E.
coliNissle 1917, as indicated by the inability of the commensals to
prevent colonization by either UPEC or EPEC (Fig. 1).
DISCUSSION
In this study, we showed that three different E. coli pathotypes
occupy distinct niches in the streptomycin-treated mouse intes-
tine (Fig. 3 and 4) and that two strains of the EHEC pathotype, E.
coli EDL933 and E. coli Sakai, occupy the same niches in the intes-
tine (Fig. 2). These findings have important implications for de-
signing strategies to prevent colonization as a means to combat E.
coli infections. Indeed, we demonstrated that a combination of
commensal E. coli strains that previously was shown to prevent
colonization by EHEC strain E. coli EDL933 (4) could not prevent
colonization of UPEC or EPEC (Fig. 1). Therefore, it is unlikely
that any particular commensal strain(s) of E. coli will be generally
effective as a probiotic to prevent colonization by E. coli patho-
gens. Freter previously postulated that the specificity of microbial
interactions in the intestine would pose a serious problem for
selecting bacterial strains with optimal attributes as probiotics
(30).
UPEC accounts for the majority of urinary tract infections in
the United States (31), and these infections often are recurring,
perhaps because the intestine serves as a reservoir for UPEC
strains (32). Thus, it is reasonable to think that preventing these
strains from colonizing the intestine would subsequently prevent
infection of the urinary tract. Likewise, if a commensal strain
could be found, or designed, to outcompete enteric pathogens
(e.g., EHEC or EPEC) for limiting nutrients, it could potentially
FIG 4 Competitive colonizations between UPEC and EPEC. (A) Two sets of 3 mice were fed 105 CFU of E. coli CFT073 Strr (UPEC) and 10 days later were fed
105 CFU of E. coli E2348/69 Strr Nalr (EPEC). (B) Two sets of 3 mice were fed 105 CFU of E. coli E2348/69 Strr (EPEC) and 10 days later were fed 105 CFU of E.
coli CFT073 Strr Nalr (UPEC).
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prevent E. coli infections, which account for up to 70% of infant
diarrhea around the world (21). Thus, it is important to develop
strategies to combat E. coli infections.
In humans, EPEC colonizes the small intestines and UPEC
causes urinary tract infections (1). Since this is a study of human
pathogens in mice, it is important to note that the streptomycin-
treatedmouse is amodel for colonization, not for pathogenesis (4,
8). Subsequently, many aspects of human intestinal infections
with E. coli, such as virulence factor expression and attachment,
are not pertinent in mice. Indeed, it was established long ago that
E. coli EDL933 does not cause an inflammatory response or elicit
disease symptoms in streptomycin-treated mice (25). Here we
show that when E. coli HS and E. coli Nissle 1917 are cocolonized
with either E. coli E2348/69 (EPEC) or E. coli CFT073 (UPEC),
both the EPEC and UPEC strains compete for the same intestinal
sites as E. coliHS andNissle 1917 (Table 2) and neither UPEC nor
EPEC elicits obvious signs of inflammation in the streptomycin-
treated mouse intestine.
According to Freter’s nutrient niche hypothesis, an intestinal
niche is defined by the nutrient(s) that supports growth of a bac-
terial population in the intestine (30). Metabolic modeling of nu-
trient utilization by 55 sequenced E. coli strains indicated modest
differences, but the authors did not use the information to predict
how the capacity to grow on certain nutrients might allow a strain
to adapt to various environments (33). We have established pre-
viously that four different human commensalE. coli strains use the
same nutrients in vitro (with one or two exceptions because the
strain lacks the corresponding pathway), but each strain uses a
subset of different nutrients in vivo, i.e., to colonize the strepto-
mycin-treatedmouse intestine (4, 5, 7–10, 14, 34). Colonized bac-
teria must effectively compete for the nutrients that allow them to
grow faster than the turnover rate of the intestinal contents, or
they will be washed out (3). This apparently includes bacteria that
have the capacity to adhere to the mucosal epithelium, since we
previously have shown that themajority of E. coli EDL933 cells are
not tightly attached but rather reside in the loosely adherent mu-
cus layer, where they can be sloughed into the intestinal contents
(10). In this regard, colonization of the streptomycin-treated
mouse intestine by E. coli follows the basic principles of Freter’s
nutrient niche hypothesis, which states that two species can coex-
ist in the intestine only if each can grow better than all others on at
least one nutrient (3).
We postulate three ways that E. coli strains compete for the
nutrients that allow them to occupy distinct niches in the intes-
tine. First, two strains can utilize different nutrients, as we have
shown first for two competing E. coli strains (8) andmore recently
for four different strains (5). For the strains tested, each E. coli
strain uses a complementary yet divergent set of seven sugars to
colonize. Second, two strains can cocolonize, despite using the
same set of sugars, by using some of those sugars better than one
another, as we have shown for isogenic flhD mutants of E. coli
K-12 that effectively outcompete their wild-type parent (12) by
growing faster on some of the same sugars. Third, two strains can
occupy different mixed biofilms (restaurants) in which different
nutrients are made available by different polysaccharide-degrad-
ing anaerobes (14). Theoretically, these strategies for nutrient ac-
quisition are not mutually exclusive, but how they intertwine to
establish the intestinal niches occupied by each ecotype and
pathotype is an open question.
Competitive colonizations between pathotypes suggest that at
least some of them occupy more than one niche, even though the
nature of those niches is not clear. When mice are precolonized
with UPEC, EPEC is nearly eliminated when associated as a chal-
lenge strain (Fig. 4A), suggesting that UPEC competes effectively
for all of the niches normally occupied by EPEC. On the other
hand, in mice precolonized with EPEC, UPEC grows to a 10-fold-
higher population (Fig. 4B), indicating thatUPECoccupies one or
more niches not occupied by EPEC. These results support the idea
that the two strains compete for someof the samenutrients and/or
restaurants but UPEC can use at least one of themmore efficiently
than EPEC.
Both UPEC and EPEC occupy niches that are not occupied by
EHEC (Fig. 3). However, the two O157:H7 EHEC strains, E. coli
EDL933 and E. coli Sakai, occupy the same niches (Fig. 2). These
two strains are genetically nearly identical, having 99.9% se-
quence identity in their protein-coding genes (29) and relatively
minor genomic differences that can be attributed to the way the
two genomes were annotated (28), and thus it is likely that the two
strains have very similar physiology, which is reflected by their
occupation of the same niches in the intestine. The distinguishing
features of the niches occupied by various E. coli ecotypes and
pathotypes, as well as distinctive aspects of their physiology and
metabolism that allows them to occupy these niches, are only par-
tially understood. What is clear is that colonized E. coli, including
invading pathogens, must compete effectively for the nutrients
they need to grow and sustain their populations. These nutrients
consist of mono- and disaccharides, as E. coli is primarily a con-
sumer of simple sugars but cannot utilize the complexmucus- and
fiber-derived polysaccharides thatmake up the bulk of carbon and
energy sources in the intestine (8). It is the job of intestinal anaer-
obes to degrade complex polysaccharides, releasing the simple
sugars that are used by other bacteria (15), including E. coli, to
colonize.
Finally, we stress that colonization is the first step in enteric
pathogenesis. Therefore, competition for the nutrients needed by
pathogens to grow from low to high numbers in the intestine is
essential for infection. A corollary of Freter’s nutrient niche hy-
pothesis is that limitation of nutrients can prevent invading strains
from colonizing (30). Indeed, Freter found that E. coli C25 could
prevent colonization by Shigella flexneri (35), and we showed that
a mixture of commensal E. coli strains could prevent colonization
by E. coli EDL933 (4, 5). But a note of caution is necessary. The
average human is colonized with 5 commensal strains (36), yet
frequent infections still occur, suggesting thatmany commensalE.
coli ecotypes cannot prevent colonization by many E. coli patho-
types. Freter summarized the probiotic field by stating that there
appears to exist a very high degree of specificity between antago-
nistic bacterial strains in the intestine (30). According to Freter’s
hypothesis, only strains that occupy the same niche will prevent
invading pathogens from colonizing, i.e., only certain E. coli com-
mensal strains will prevent colonization by other E. coli strains.
Our study extends the idea that no single strain or combination of
E. coli strains will prevent colonization by different E. coli patho-
types.While itmight be possible to search for and find commensal
E. coli strains that will exert colonization resistance against each E.
coli pathotype, at this time we do not possess the knowledge
needed to design a broad-spectrum probiotic strain, highlighting
the need for a deeper understanding of the factors that contribute
to the colonization of the mammalian gastrointestinal tract by E.
coli.
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